PAS
AQST icon

Point72 Asia (Singapore)’s Aquestive Therapeutics AQST Stock Holding History

Point72 Asia (Singapore)’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,957
Closed -$174K – 1046
2024
Q1 		$174K Buy
+40,957
New +$136K 0.05% 486

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Point72 Asia (Singapore)'s AQST Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Aquestive Therapeutics (AQST) in Q2 2024, closing a stake of 40,957 shares — an estimated $174K sold.

Point72 Asia (Singapore) first reported a position in AQST in Q1 2024 and held it in 1 quarter. The position peaked at $174K in Q1 2024. 97 funds tracked by Wall St. Rank hold AQST as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Aquestive Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 40,957 Aquestive Therapeutics shares in Q2 2024, an estimated $174K.
  • Point72 Asia (Singapore) first reported a position in Aquestive Therapeutics in Q1 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Aquestive Therapeutics position peaked at $174K in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.